Canadian Inborn Errors of Immunity National Registry – an observational, longitudinal research study design for a Rare Disease Registry Model with Governance Framework and Enhanced Interoperability

Background Inborn errors of immunity (IEI) are individually rare but collectively affect an estimated 30,000 Canadians. Their genetic and clinical heterogeneity, combined with limited disease-specific data, presents challenges in diagnosis, management, and evaluation of treatment outcomes. A national registry with standardized longitudinal data collection is needed to better characterize disease manifestations, support clinical research, inform healthcare planning, and improve care for individuals with IEI across Canada. Methods A national steering committee comprising 13 clinician-researchers from 3 adult and 8 pediatric centres across 9 Canadian provinces established the Canadian Inborn Errors of Immunity National Registry (CIEINR). Development was informed by an environmental scan of existing rare disease registries and consultations with bioinformatics experts and patient representatives. A multidomain electronic case report form (eCRF) was developed using Research Electronic Data Capture (REDCap), hosted at the University of Calgary, to systematically collect demographic, genetic, clinical, treatment, and outcome data. Results Between 2021 and 2025, the CIEINR governance framework, research protocols, and standardized data model were developed and peer-reviewed. The eCRF incorporates ontology-based medical terminologies to facilitate standardized characterization of clinical manifestations, data harmonization, and interoperability. The RareLink framework was adapted to support internationally standardized data linkage and generation of Global Alliance for Genomics and Health (GA4GH) Phenopackets, enabling structured, machine-readable representation of clinical and genomic information. Registry governance documents, policies, and data models are shared through an open-access GitHub repository to promote transparency, reproducibility, and collaboration. Conclusions The innovative CIEINR provides a national infrastructure for standardized, longitudinal collection of diagnosis, disease course, treatment, outcomes, and genomic data ac across the spectrum of IEI. High-quality, standardized, machine-readable, and interoperable data will enable Phenopacket analysis, support research on new therapies, and foster international collaboration. By openly sharing its governance framework, policies, and data model, CIEINR establishes a reproducible approach to rare disease registry development while advancing evidence-based clinical care, patient advocacy, and healthcare policy.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11614542/v1
Primary Topic
Immunodeficiency and Autoimmune Disorders
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Canadian Inborn Errors of Immunity National Registry – an observational, longitudinal research study design for a Rare Disease Registry Model with Governance Framework and Enhanced Interoperability

Sneha Suresh, Brenda Turley, Catherine M. Biggs, Nicola A. M. Wright et al.
4 links
Research Square
Immunodeficiency and Autoimmune Disorders
preprint

Canadian Inborn Errors of Immunity National Registry – an observational, longitudinal research study design for a Rare Disease Registry Model with Governance Framework and Enhanced Interoperability

Sneha Suresh, Brenda Turley, Catherine M. Biggs, Nicola A. M. Wright, Whitney Ayoub Goulstone, Hugo Chapdelaine, Peter N. Robinson, Luis E. Murguía-Favela, Ashley V. Geerlinks, Tamar S. Rubin, Daniel Daniš, Beáta Dérfalvi, Sylvia Thun, Oya Beyan, Rae Brager, Eyal Grunebaum, Bruce C. Ritchie, Juthaporn Cowan, Alyssa Alger, Mandi Uppal, Adam S L Graefe, Jennifer K. Grossman, Tatiana Kalashnikova, Taylor Mattinson, Hanna Huska, Lavindu Senadheera, Candace Rusling, Rouven Reuter
preprint en

Abstract

Background Inborn errors of immunity (IEI) are individually rare but collectively affect an estimated 30,000 Canadians. Their genetic and clinical heterogeneity, combined with limited disease-specific data, presents challenges in diagnosis, management, and evaluation of treatment outcomes. A national registry with standardized longitudinal data collection is needed to better characterize disease manifestations, support clinical research, inform healthcare planning, and improve care for individuals with IEI across Canada. Methods A national steering committee comprising 13 clinician-researchers from 3 adult and 8 pediatric centres across 9 Canadian provinces established the Canadian Inborn Errors of Immunity National Registry (CIEINR). Development was informed by an environmental scan of existing rare disease registries and consultations with bioinformatics experts and patient representatives. A multidomain electronic case report form (eCRF) was developed using Research Electronic Data Capture (REDCap), hosted at the University of Calgary, to systematically collect demographic, genetic, clinical, treatment, and outcome data. Results Between 2021 and 2025, the CIEINR governance framework, research protocols, and standardized data model were developed and peer-reviewed. The eCRF incorporates ontology-based medical terminologies to facilitate standardized characterization of clinical manifestations, data harmonization, and interoperability. The RareLink framework was adapted to support internationally standardized data linkage and generation of Global Alliance for Genomics and Health (GA4GH) Phenopackets, enabling structured, machine-readable representation of clinical and genomic information. Registry governance documents, policies, and data models are shared through an open-access GitHub repository to promote transparency, reproducibility, and collaboration. Conclusions The innovative CIEINR provides a national infrastructure for standardized, longitudinal collection of diagnosis, disease course, treatment, outcomes, and genomic data ac across the spectrum of IEI. High-quality, standardized, machine-readable, and interoperable data will enable Phenopacket analysis, support research on new therapies, and foster international collaboration. By openly sharing its governance framework, policies, and data model, CIEINR establishes a reproducible approach to rare disease registry development while advancing evidence-based clinical care, patient advocacy, and healthcare policy.

Research Square
Western University (CA), Alberta Health Services (CA), Dalhousie University (CA), University of British Columbia (CA), University of Ottawa (CA), University of Alberta (CA), University of Calgary (CA), University of Toronto (CA), McMaster Children's Hospital (CA), Alberta Children's Hospital (CA), Immunité et Cancer (FR), Children's Hospital of Winnipeg (CA), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), University Hospital Cologne (DE), Institute of Infection and Immunity (CA), University of Manitoba (CA), Université de Montréal (CA), Charité - Universitätsmedizin Berlin (DE), McMaster University (CA)
US Immunodeficiency Network, Immunodeficiency Canada, Albert-Ludwigs-Universität Freiburg, Dalhousie University, Grifols, Takeda Canada
Good health and well-being, Reduced inequalities
Immunodeficiency and Autoimmune Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon